Sabar Pambudi

Dr. Sabar Pambudi


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2022 in Sensors
Verified
Journal Article
Open access
PDF file
SMSjaikhurrizal El Muttaqien
Sjaikhurrizal El Muttaqien
IKIndra Memdi Khoris
Indra Memdi Khoris
SPSabar Pambudi
Sabar Pambudi
Enoch Y. ParkEnoch Y. Park
Enoch Y. Park
Nanomaterials have been explored in the sensing research field in the last decades. Mainly, 3D nanomaterials have played a vital role in advancing biomedical applications, and less attention was given to their application in the field of biosensors for pathogenic virus detection. The versatility and tunability of a wide range of nanomaterials contributed to the development of a rapid, portable biosensor platform. In this review, we discuss 3D nanospheres, one of the classes of nanostructured materials with a homogeneous and dense matrix wherein a guest substance is carried within the matrix or on its surface. This review is segmented based on the type of nanosphere and their elaborative application in various sensing techniques. We emphasize the concept of signal amplification strategies using different nanosphere structures constructed from a polymer, carbon, silica, and metal–organic framework (MOF) for rendering high-level sensitivity of virus detection. We also briefly elaborate on some challenges related to the further development of nanosphere-based biosensors, including the toxicity issue of the used nanomaterial and the commercialization hurdle.

4 March 2024 in Microchimica Acta
Verified
Journal Article
Closed access
PDF file
SMSjaikhurrizal El Muttaqien
Sjaikhurrizal El Muttaqien
IKIndra Memdi Khoris
Indra Memdi Khoris
JSJodi Suryanggono
Jodi Suryanggono
PSProvash Chandra Sadhukhan
Provash Chandra Sadhukhan
SPSabar Pambudi
Sabar Pambudi
Enoch Y. ParkEnoch Y. Park
Enoch Y. Park

31 January 2022 in AMB Express
Verified
Journal Article
Open access
PDF file
DUDoddy Irawan Setyo Utomo
Doddy Irawan Setyo Utomo
SPSabar Pambudi
Sabar Pambudi
Enoch Y. ParkEnoch Y. Park
Enoch Y. Park
Dengue is an arboviral disease, which threatens almost half the global population, and has emerged as the most significant of current global public health challenges. In this study, we prepared dengue virus-like particles (DENV-LPs) consisting of Capsid-premembrane-envelope (CprME) and premembrane-envelope (prME) polypeptides from serotype 1 and 4, which were expressed in the silkworms using Bombyx mori nucleopolyhedrovirus (BmNPV) bacmid. 1CprME, 1prME, 4CprME, and 4prME expressed proteins in hemolymph, and the molecular weight of the purified proteins was 55 kDa, respectively. The purified polypeptides formed spherical Dengue virus-like particles (DENV-LPs) with ~ 30–55 nm in diameter. The immunoelectron microscopy (IEM) images revealed antigens to the surface of a lipid bilayer of DENV-LPs. The heparin-binding assay shows a positive relationship between absorbance and E protein domain III (EDIII) quantity, which is supported by the isothermal titration calorimetry assay. This indicates a moderate binding affinity between heparin and DENV-LP. The high correlation between patient sera and DENV-LP reactivities revealed that these DENV-LPs shared similar epitopes with the natural dengue virus. IgG elicitation studies in mice have demonstrated that DENV-LPs/CPrMEs elicit a stronger immune response than DENV-LP/prMEs, which lends credence to this claim.

25 February 2023
Verified
Book Chapter
Open access
PDF file
SPSabar Pambudi
Sabar Pambudi
TWTika Widayanti
Tika Widayanti
FNFebby N. Ningsih
Febby N. Ningsih
ASAsri Sulfianti
Asri Sulfianti
JSJodi Suryanggono
Jodi Suryanggono
INIka Nurlaila
Ika Nurlaila
One of the abundant biomarkers in tuberculosis (TB) infected human serum is the Ag85B antigen. The quest for protein biomarkers has been conducted to develop a diagnostic kit and vaccine for TB. Numerous studies have demonstrated that the development of monoclonal antibodies (mAbs) that recognize a specific repertoire of Mycobacterium tuberculosis antigens and the tests based on monoclonal antibodies have proved helpful in TB detection. Unfortunately, numerous mAbs currently used for TB serodiagnosis were generated elsewhere. Improving the ability to produce mouse monoclonal antibodies, specifically against Ag85B, is imperative as Indonesia is the second prevalent TB country. Therefore, a synthetic plasmid expressing Ag85B-HA fusion protein was expressed in the mammalian system. The expression of Ag85B protein in the 293T cells lysates was confirmed by western blot analysis. A specific protein band around 36 kDa appeared against antibody anti-HA. The lysate of recombinant mammalian cells was used as an inducer to generate B-cells expressing mouse monoclonal antibodies anti-Ag85B. By fusing ‘PAI’ mouse myeloma cells and B-cells from immunized mice, hybridoma mAb-producing cells were obtained. As many as 43 hybridomas cells were tested against recombinant Ag85B antigen by immunofluorescence assay (IFA). We found two (2) hybridomas cells specifically secreting monoclonal antibody anti-Ag85B. One hybridoma, 3C12 clone, was confirmed to have the ability to recognize Ag85B protein validated by western blot analysis. Similar to previous research, our western blot analysis shows that our monoclonal antibody can identify the antigen Ag85 at a protein size of around 30 kDa. Further analysis and characterization should be conducted to explore the potency of those monoclonal antibodies for developing TB diagnostic kits.